0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Healthcare Infection Surveillance Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-24G16997
Home | Market Reports | Law & Government| Public Safety
Global Healthcare Infection Surveillance Service Market Research Report 2024
BUY CHAPTERS

Global Healthcare Infection Surveillance Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-24G16997
Report
November 2025
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Healthcare Infection Surveillance Service Market

The global Healthcare Infection Surveillance Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospitals & Clinics accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Healthcare Infection Surveillance Service leading manufacturers including Baxter International Inc., Wolters Kluwer, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., Alpha Source Inc., RLDatixS. C., BD, BioVigil, Johnson & Son, etc., dominate supply; the top five capture approximately % of global revenue, with Baxter International Inc. leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Healthcare Infection Surveillance Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Healthcare Infection Surveillance Service Market Report

Report Metric Details
Report Name Healthcare Infection Surveillance Service Market
Segment by Type
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infections (UTI)
  • Others
Segment by Application
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Academic Institutes
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Baxter International Inc., Wolters Kluwer, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., Alpha Source Inc., RLDatixS. C., BD, BioVigil, Johnson & Son
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Healthcare Infection Surveillance Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Healthcare Infection Surveillance Service Market report?

Ans: The main players in the Healthcare Infection Surveillance Service Market are Baxter International Inc., Wolters Kluwer, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., Alpha Source Inc., RLDatixS. C., BD, BioVigil, Johnson & Son

What are the Application segmentation covered in the Healthcare Infection Surveillance Service Market report?

Ans: The Applications covered in the Healthcare Infection Surveillance Service Market report are Hospitals & Clinics, Ambulatory Surgical Centers, Academic Institutes, Others

What are the Type segmentation covered in the Healthcare Infection Surveillance Service Market report?

Ans: The Types covered in the Healthcare Infection Surveillance Service Market report are Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI), Others

1 Study Coverage
1.1 Introduction to Healthcare Infection Surveillance Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Healthcare Infection Surveillance Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Bloodstream Infections
1.2.3 Surgical Site Infections
1.2.4 Gastrointestinal Infections
1.2.5 Urinary Tract Infections (UTI)
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Healthcare Infection Surveillance Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals & Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Academic Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Healthcare Infection Surveillance Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Healthcare Infection Surveillance Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Healthcare Infection Surveillance Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Healthcare Infection Surveillance Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Bloodstream Infections Market Size by Players
3.3.2 Surgical Site Infections Market Size by Players
3.3.3 Gastrointestinal Infections Market Size by Players
3.3.4 Urinary Tract Infections (UTI) Market Size by Players
3.3.5 Others Market Size by Players
3.4 Global Healthcare Infection Surveillance Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Healthcare Infection Surveillance Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Healthcare Infection Surveillance Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Healthcare Infection Surveillance Service Market Size by Type (2020-2031)
6.4 North America Healthcare Infection Surveillance Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Healthcare Infection Surveillance Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Healthcare Infection Surveillance Service Market Size by Type (2020-2031)
7.4 Europe Healthcare Infection Surveillance Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Healthcare Infection Surveillance Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Healthcare Infection Surveillance Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Healthcare Infection Surveillance Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Healthcare Infection Surveillance Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Healthcare Infection Surveillance Service Market Size by Type (2020-2031)
9.4 Central and South America Healthcare Infection Surveillance Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Healthcare Infection Surveillance Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Healthcare Infection Surveillance Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Healthcare Infection Surveillance Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Healthcare Infection Surveillance Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Business Overview
11.1.3 Baxter International Inc. Healthcare Infection Surveillance Service Product Features and Attributes
11.1.4 Baxter International Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (2020-2025)
11.1.5 Baxter International Inc. Healthcare Infection Surveillance Service Revenue by Product in 2024
11.1.6 Baxter International Inc. Healthcare Infection Surveillance Service Revenue by Application in 2024
11.1.7 Baxter International Inc. Healthcare Infection Surveillance Service Revenue by Geographic Area in 2024
11.1.8 Baxter International Inc. Healthcare Infection Surveillance Service SWOT Analysis
11.1.9 Baxter International Inc. Recent Developments
11.2 Wolters Kluwer
11.2.1 Wolters Kluwer Corporation Information
11.2.2 Wolters Kluwer Business Overview
11.2.3 Wolters Kluwer Healthcare Infection Surveillance Service Product Features and Attributes
11.2.4 Wolters Kluwer Healthcare Infection Surveillance Service Revenue and Gross Margin (2020-2025)
11.2.5 Wolters Kluwer Healthcare Infection Surveillance Service Revenue by Product in 2024
11.2.6 Wolters Kluwer Healthcare Infection Surveillance Service Revenue by Application in 2024
11.2.7 Wolters Kluwer Healthcare Infection Surveillance Service Revenue by Geographic Area in 2024
11.2.8 Wolters Kluwer Healthcare Infection Surveillance Service SWOT Analysis
11.2.9 Wolters Kluwer Recent Developments
11.3 Gojo Industries Inc.
11.3.1 Gojo Industries Inc. Corporation Information
11.3.2 Gojo Industries Inc. Business Overview
11.3.3 Gojo Industries Inc. Healthcare Infection Surveillance Service Product Features and Attributes
11.3.4 Gojo Industries Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (2020-2025)
11.3.5 Gojo Industries Inc. Healthcare Infection Surveillance Service Revenue by Product in 2024
11.3.6 Gojo Industries Inc. Healthcare Infection Surveillance Service Revenue by Application in 2024
11.3.7 Gojo Industries Inc. Healthcare Infection Surveillance Service Revenue by Geographic Area in 2024
11.3.8 Gojo Industries Inc. Healthcare Infection Surveillance Service SWOT Analysis
11.3.9 Gojo Industries Inc. Recent Developments
11.4 International Business Machines Corporation
11.4.1 International Business Machines Corporation Corporation Information
11.4.2 International Business Machines Corporation Business Overview
11.4.3 International Business Machines Corporation Healthcare Infection Surveillance Service Product Features and Attributes
11.4.4 International Business Machines Corporation Healthcare Infection Surveillance Service Revenue and Gross Margin (2020-2025)
11.4.5 International Business Machines Corporation Healthcare Infection Surveillance Service Revenue by Product in 2024
11.4.6 International Business Machines Corporation Healthcare Infection Surveillance Service Revenue by Application in 2024
11.4.7 International Business Machines Corporation Healthcare Infection Surveillance Service Revenue by Geographic Area in 2024
11.4.8 International Business Machines Corporation Healthcare Infection Surveillance Service SWOT Analysis
11.4.9 International Business Machines Corporation Recent Developments
11.5 Premier Inc.
11.5.1 Premier Inc. Corporation Information
11.5.2 Premier Inc. Business Overview
11.5.3 Premier Inc. Healthcare Infection Surveillance Service Product Features and Attributes
11.5.4 Premier Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (2020-2025)
11.5.5 Premier Inc. Healthcare Infection Surveillance Service Revenue by Product in 2024
11.5.6 Premier Inc. Healthcare Infection Surveillance Service Revenue by Application in 2024
11.5.7 Premier Inc. Healthcare Infection Surveillance Service Revenue by Geographic Area in 2024
11.5.8 Premier Inc. Healthcare Infection Surveillance Service SWOT Analysis
11.5.9 Premier Inc. Recent Developments
11.6 Alpha Source Inc.
11.6.1 Alpha Source Inc. Corporation Information
11.6.2 Alpha Source Inc. Business Overview
11.6.3 Alpha Source Inc. Healthcare Infection Surveillance Service Product Features and Attributes
11.6.4 Alpha Source Inc. Healthcare Infection Surveillance Service Revenue and Gross Margin (2020-2025)
11.6.5 Alpha Source Inc. Recent Developments
11.7 RLDatixS. C.
11.7.1 RLDatixS. C. Corporation Information
11.7.2 RLDatixS. C. Business Overview
11.7.3 RLDatixS. C. Healthcare Infection Surveillance Service Product Features and Attributes
11.7.4 RLDatixS. C. Healthcare Infection Surveillance Service Revenue and Gross Margin (2020-2025)
11.7.5 RLDatixS. C. Recent Developments
11.8 BD
11.8.1 BD Corporation Information
11.8.2 BD Business Overview
11.8.3 BD Healthcare Infection Surveillance Service Product Features and Attributes
11.8.4 BD Healthcare Infection Surveillance Service Revenue and Gross Margin (2020-2025)
11.8.5 BD Recent Developments
11.9 BioVigil
11.9.1 BioVigil Corporation Information
11.9.2 BioVigil Business Overview
11.9.3 BioVigil Healthcare Infection Surveillance Service Product Features and Attributes
11.9.4 BioVigil Healthcare Infection Surveillance Service Revenue and Gross Margin (2020-2025)
11.9.5 BioVigil Recent Developments
11.10 Johnson & Son
11.10.1 Johnson & Son Corporation Information
11.10.2 Johnson & Son Business Overview
11.10.3 Johnson & Son Healthcare Infection Surveillance Service Product Features and Attributes
11.10.4 Johnson & Son Healthcare Infection Surveillance Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Healthcare Infection Surveillance ServiceIndustry Chain Analysis
12.1 Healthcare Infection Surveillance Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Healthcare Infection Surveillance Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Healthcare Infection Surveillance Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Healthcare Infection Surveillance Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Healthcare Infection Surveillance Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Healthcare Infection Surveillance Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Healthcare Infection Surveillance Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Healthcare Infection Surveillance Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare Infection Surveillance Service as of 2024)
 Table 11. Global Healthcare Infection Surveillance Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Healthcare Infection Surveillance Service Companies Headquarters
 Table 13. Global Healthcare Infection Surveillance Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Healthcare Infection Surveillance Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Healthcare Infection Surveillance Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Healthcare Infection Surveillance Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Healthcare Infection Surveillance Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Healthcare Infection Surveillance Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Healthcare Infection Surveillance Service Growth Accelerators and Market Barriers
 Table 25. North America Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Healthcare Infection Surveillance Service Growth Accelerators and Market Barriers
 Table 27. Europe Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Healthcare Infection Surveillance Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Healthcare Infection Surveillance Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Healthcare Infection Surveillance Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Healthcare Infection Surveillance Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Baxter International Inc. Corporation Information
 Table 35. Baxter International Inc. Description and Major Businesses
 Table 36. Baxter International Inc. Product Features and Attributes
 Table 37. Baxter International Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Baxter International Inc. Revenue Proportion by Product in 2024
 Table 39. Baxter International Inc. Revenue Proportion by Application in 2024
 Table 40. Baxter International Inc. Revenue Proportion by Geographic Area in 2024
 Table 41. Baxter International Inc. Healthcare Infection Surveillance Service SWOT Analysis
 Table 42. Baxter International Inc. Recent Developments
 Table 43. Wolters Kluwer Corporation Information
 Table 44. Wolters Kluwer Description and Major Businesses
 Table 45. Wolters Kluwer Product Features and Attributes
 Table 46. Wolters Kluwer Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Wolters Kluwer Revenue Proportion by Product in 2024
 Table 48. Wolters Kluwer Revenue Proportion by Application in 2024
 Table 49. Wolters Kluwer Revenue Proportion by Geographic Area in 2024
 Table 50. Wolters Kluwer Healthcare Infection Surveillance Service SWOT Analysis
 Table 51. Wolters Kluwer Recent Developments
 Table 52. Gojo Industries Inc. Corporation Information
 Table 53. Gojo Industries Inc. Description and Major Businesses
 Table 54. Gojo Industries Inc. Product Features and Attributes
 Table 55. Gojo Industries Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Gojo Industries Inc. Revenue Proportion by Product in 2024
 Table 57. Gojo Industries Inc. Revenue Proportion by Application in 2024
 Table 58. Gojo Industries Inc. Revenue Proportion by Geographic Area in 2024
 Table 59. Gojo Industries Inc. Healthcare Infection Surveillance Service SWOT Analysis
 Table 60. Gojo Industries Inc. Recent Developments
 Table 61. International Business Machines Corporation Corporation Information
 Table 62. International Business Machines Corporation Description and Major Businesses
 Table 63. International Business Machines Corporation Product Features and Attributes
 Table 64. International Business Machines Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. International Business Machines Corporation Revenue Proportion by Product in 2024
 Table 66. International Business Machines Corporation Revenue Proportion by Application in 2024
 Table 67. International Business Machines Corporation Revenue Proportion by Geographic Area in 2024
 Table 68. International Business Machines Corporation Healthcare Infection Surveillance Service SWOT Analysis
 Table 69. International Business Machines Corporation Recent Developments
 Table 70. Premier Inc. Corporation Information
 Table 71. Premier Inc. Description and Major Businesses
 Table 72. Premier Inc. Product Features and Attributes
 Table 73. Premier Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Premier Inc. Revenue Proportion by Product in 2024
 Table 75. Premier Inc. Revenue Proportion by Application in 2024
 Table 76. Premier Inc. Revenue Proportion by Geographic Area in 2024
 Table 77. Premier Inc. Healthcare Infection Surveillance Service SWOT Analysis
 Table 78. Premier Inc. Recent Developments
 Table 79. Alpha Source Inc. Corporation Information
 Table 80. Alpha Source Inc. Description and Major Businesses
 Table 81. Alpha Source Inc. Product Features and Attributes
 Table 82. Alpha Source Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Alpha Source Inc. Recent Developments
 Table 84. RLDatixS. C. Corporation Information
 Table 85. RLDatixS. C. Description and Major Businesses
 Table 86. RLDatixS. C. Product Features and Attributes
 Table 87. RLDatixS. C. Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. RLDatixS. C. Recent Developments
 Table 89. BD Corporation Information
 Table 90. BD Description and Major Businesses
 Table 91. BD Product Features and Attributes
 Table 92. BD Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. BD Recent Developments
 Table 94. BioVigil Corporation Information
 Table 95. BioVigil Description and Major Businesses
 Table 96. BioVigil Product Features and Attributes
 Table 97. BioVigil Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. BioVigil Recent Developments
 Table 99. Johnson & Son Corporation Information
 Table 100. Johnson & Son Description and Major Businesses
 Table 101. Johnson & Son Product Features and Attributes
 Table 102. Johnson & Son Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Johnson & Son Recent Developments
 Table 104. Raw Materials Key Suppliers
 Table 105. Distributors List
 Table 106. Market Trends and Market Evolution
 Table 107. Market Drivers and Opportunities
 Table 108. Market Challenges, Risks, and Restraints
 Table 109. Research Programs/Design for This Report
 Table 110. Key Data Information from Secondary Sources
 Table 111. Key Data Information from Primary Sources


List of Figures
 Figure 1. Healthcare Infection Surveillance Service Product Picture
 Figure 2. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Bloodstream Infections Product Picture
 Figure 4. Surgical Site Infections Product Picture
 Figure 5. Gastrointestinal Infections Product Picture
 Figure 6. Urinary Tract Infections (UTI) Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Healthcare Infection Surveillance Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Hospitals & Clinics
 Figure 10. Ambulatory Surgical Centers
 Figure 11. Academic Institutes
 Figure 12. Others
 Figure 13. Healthcare Infection Surveillance Service Report Years Considered
 Figure 14. Global Healthcare Infection Surveillance Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 16. Global Healthcare Infection Surveillance Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 17. Global Healthcare Infection Surveillance Service Revenue Market Share by Region (2020-2031)
 Figure 18. Global Healthcare Infection Surveillance Service Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Bloodstream Infections Revenue Market Share by Player in 2024
 Figure 21. Surgical Site Infections Revenue Market Share by Player in 2024
 Figure 22. Gastrointestinal Infections Revenue Market Share by Player in 2024
 Figure 23. Urinary Tract Infections (UTI) Revenue Market Share by Player in 2024
 Figure 24. Others Revenue Market Share by Player in 2024
 Figure 25. Global Healthcare Infection Surveillance Service Revenue Market Share by Type (2020-2031)
 Figure 26. Global Healthcare Infection Surveillance Service Revenue Market Share by Application (2020-2031)
 Figure 27. North America Healthcare Infection Surveillance Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Players Healthcare Infection Surveillance Service Revenue (US$ Million) in 2024
 Figure 29. North America Healthcare Infection Surveillance Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Healthcare Infection Surveillance Service Revenue (US$ Million) by Application (2020-2031)
 Figure 31. US Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 32. Canada Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 33. Mexico Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 34. Europe Healthcare Infection Surveillance Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 35. Europe Top 5 Players Healthcare Infection Surveillance Service Revenue (US$ Million) in 2024
 Figure 36. Europe Healthcare Infection Surveillance Service Revenue (US$ Million) by Type (2020-2031)
 Figure 37. Europe Healthcare Infection Surveillance Service Revenue (US$ Million) by Application (2020-2031)
 Figure 38. Germany Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 39. France Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 40. U.K. Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 41. Italy Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 42. Russia Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific Healthcare Infection Surveillance Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 44. Asia-Pacific Top 8 Players Healthcare Infection Surveillance Service Revenue (US$ Million) in 2024
 Figure 45. Asia-Pacific Healthcare Infection Surveillance Service Revenue (US$ Million) by Type (2020-2031)
 Figure 46. Asia-Pacific Healthcare Infection Surveillance Service Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Indonesia Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Japan Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 49. South Korea Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Australia Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 51. India Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 52. Indonesia Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 53. Vietnam Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 54. Malaysia Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 55. Philippines Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 56. Singapore Healthcare Infection Surveillance Service Revenue (2020-2031) & (US$ Million)
 Figure 57. Central and South America Healthcare Infection Surveillance Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Central and South America Top 5 Players Healthcare Infection Surveillance Service Revenue (US$ Million) in 2024
 Figure 59. Central and South America Healthcare Infection Surveillance Service Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Central and South America Healthcare Infection Surveillance Service Revenue (US$ Million) by Application (2020-2031)
 Figure 61. Brazil Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
 Figure 62. Argentina Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
 Figure 63. Middle East and Africa Healthcare Infection Surveillance Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Middle East and Africa Top 5 Players Healthcare Infection Surveillance Service Revenue (US$ Million) in 2024
 Figure 65. South America Healthcare Infection Surveillance Service Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Middle East and Africa Healthcare Infection Surveillance Service Revenue (US$ Million) by Application (2020-2031)
 Figure 67. GCC Countries Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
 Figure 68. Israel Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
 Figure 69. Egypt Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
 Figure 70. South Africa Healthcare Infection Surveillance Service Revenue (2020-2025) & (US$ Million)
 Figure 71. Healthcare Infection Surveillance Service Industry Chain Mapping
 Figure 72. Channels of Distribution (Direct Vs Distribution)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture